Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV

Virology(2021)10.1016/j.virol.2021.06.006Source: DataRank Database

Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV is a research paper published in Virology (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.57)OA: greenTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Wei Bu ORCID,Sohtaro Mine ORCID,Zeshan Tariq ORCID,Hanh Nguyen ORCID,Yanmei Wang ORCID

Live enrichment

PubMed:34171765 PMC:PMC8803478 OpenAlex:https://openalex.org/W3176319968

CCR NIH HHS

Grant: HHSN261200800001C

Intramural NIH HHS

Grant: Z01 AI000978

NCI NIH HHS

Grant: HHSN261200800001E

NIAID NIH HHS

Grant: T32 AI125186

FWCI

0.57

Citation Percentile

0.7%

Citation Trend

2021

2022

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8803478

publisherhttps://api.elsevier.com/content/article/PII:S0042682221001367?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0042682221001367?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.virol.2021.06.006

Fields of Study

Viral-associated cancers and disordersImmunodeficiency and Autoimmune DisordersLymphoma Diagnosis and Treatment

MeSH Terms

AnimalsAntibodies, ViralB-LymphocytesBlood DonorsHerpesvirus 4, HumanImmunization, PassiveViral Matrix ProteinsViral LoadEpstein-Barr Virus InfectionsMiceAntibodies, Neutralizing

Keywords

VirologyImmunologyAntibodyTiterVirusBiologyLymphoproliferative diseaseEpstein–Barr virusViral loadNeutralizing antibodyHerpesvirusEpstein-Barr virusHyperimmune GlobulinGlycoprotein 350

Sustainable Development Goals

SDG 0: Good health and well-being